Clinical Nutrition Market Size To Reach $55.92 Billion By 2033

September 2025 | Report Format: Electronic (PDF)

Clinical Nutrition Market Growth & Trends

The global clinical nutrition market size is expected to reach USD 55.92 billion by 2033, registering a CAGR of 6.37% from 2025 to 2033, according to a new report by Grand View Research, Inc. The rising geriatric population and prevalence of chronic diseases coupled with innovation in personalized and targeted solutions and advancement in healthcare infrastructure are some of the factors driving the growth of market.

According to the World Health Organization (WHO), the global population aged 60 years and older is expected to surge from approximately 1 billion in 2020 to about 1.4 billion in 2030, projected to nearly double to approximately 2.1 billion by 2050. Over recent years, there has been a significant rise in the number of older individuals diagnosed with critical health conditions. Furthermore, various studies published by the National Center for Biotechnology Information (NCBI) indicate that individuals aged 65 and above are at an elevated risk of developing chronic diseases, including Alzheimer's disease, Parkinson's disease, and other neurological disorders.

For example, the Alzheimer's Association reports that out of the 5.5 million Americans affected by Alzheimer's disease, an estimated 5.3 million are 65 years or older. Consequently, healthcare professionals are increasingly focusing on optimizing clinical nutrition interventions for older adults, thereby boosting the market growth. Moreover, the aging process compromises the immune system, heightening vulnerability to infectious diseases and impacting essential bodily functions. Myelodysplastic syndromes, characterized by reduced blood cell production leading to inadequate and/or immature red blood cells, elevate the risk of infection and complications related to anemia, consequently driving demand for enteral feeding formulas.

Rising incidence of targeted diseases and advancements in drug development are expected to drive the demand for disease-specific formulas. Clinical nutrition is extensively used for the personalized treatment of diseases, such as cystic fibrosis, cancer, and so on. Prominent companies such as Nestlé specialize in personalized clinical nutrition products, which include Deplin for depression and Metanx for diabetes. Deplin is different from nonprescription folic acid, as it contains already-activated folate. It is to be noted that 70% of the patients suffering from depression have a low ability to activate folate, and therefore, the demand for medical foods, such as Deplin, has increased for various nonmetabolizing patients. These factors are likely to drive the demand for clinical nutrition by helping enhance the effectiveness of the treatment and improving the overall quality of medical treatment

The COVID-19 pandemic has led to a rise in the burden on healthcare services and an increase in the treatment sensitivity of critically ill patients. Patients who tested positive for COVID-19 often experience weakened immunity and disruption in respiratory & other systems. For instance, as highlighted in a publication from Elsevier's Public Health Emergency Collection, nearly half of severely ill COVID-19 patients manifest gastrointestinal complications such as hypomotility. In addition, patients experienced various other abdominal problems, leading to an increase in the adoption of clinical nutrition at global and country levels.

Furthermore, numerous studies justified the utilization of parenteral nutrition for individuals experiencing malnutrition issues, which raised during the pandemic, thereby contributing to market expansion. For instance, as per an article published in the Journal of the Academy of Nutrition and Dietetics, patients admitted to the ICU for COVID-19 treatment suffered from acute malnourishment. This raised the usage of parenteral nutrition products increased in the market during the pandemic.

Various initiatives undertaken by key players in the market to strengthen its position is positively impacting the market growth. For instance, in March 2023, Danone acquired ProMedica, a Poland-based company that specializes in providing care services for patients in their homes. This acquisition is part of Danone's lucrative specialized nutrition market expansion strategy, to strengthen its presence in Poland.Similarly, in January 2023, Nestle announced an investment of USD 43 million to expand its manufacturing facility in Eau Claire, Wisconsin in the U.S.

key Request a free sample copy or view report summary: Clinical Nutrition Market Report

Clinical Nutrition Market Report Highlights

The oral nutrition segment led the market with the largest revenue share of 54.3% in 2024. The parenteral nutrition segment is expected to grow at the fastest CAGR over the forecast period.
The cancer care segment led the market with the largest revenue share of 15.1% in 2024. The malabsorption/GI disorder/diarrhea segment is anticipated to grow at the fastest CAGR over the forecast period.
The institutional sales channel segment led the market with the largest revenue share of 46.1% in 2024. The online sales channel segment is anticipated to witness the fastest CAGR during the forecast period.
North America dominated the global clinical nutrition market with the largest revenue share of 32.6% in 2024. The clinical nutrition market in the U.S. accounted for the largest market revenue share in North America in 2024.
The clinical nutrition market in the Asia Pacific is anticipated to witness the fastest CAGR over the forecast period.

Clinical Nutrition Market Segmentation

Grand View Research has segmented global clinical nutrition market report based on product, application, sales channel, and region:

Clinical Nutrition Product Outlook (Revenue, USD Million, 2021 - 2033)

Oral Clinical Nutrition
Parenteral Nutrition
- Carbohydrates
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solutions
- Trace Elements
- Vitamins & Minerals
Enteral Feeding Formulas
- Standard Formula
- Disease-specific Formulas